Witte F, Hönig A, Mirecka J, Schauer A
Department of Pathology, Georg-August-Universität Göttingen, Germany.
Anticancer Res. 1999 Jul-Aug;19(4B):3355-9.
Cystosarcoma phyllodes (CP) is a rare fibroepithelial tumor of the breast. So far no valuable prognostic factors are available for predicting the biological behaviour and often unexpected clinical outcome of this tumor.
Using immuno-histochemistry, Mib-1 evaluated proliferative activity and expression of p53, Bcl-2, c-erbB1, c-erbB2, cytokeratin and vimentin were analysed in 17 benign and 12 malignant CP.
Cell proliferation was significantly higher in malignant tumors compared to benign ones both in the epithelial and mesenchymal parts. In the epithelial part Bcl-2 positive cells were found more frequently in benign than in malignant lesions. Positive immunoreactivity for p53 was seen in only one malignant case. The reaction was positive in the both epithelial and mesenchymal compartments. Expression of c-erbB-proteins was not found in any case. The intermediate filament proteins indicate clearly the two components of the tumor.
We concluded that increased proliferate activity and downregulation of Bcl-2 may be associated with dedifferentiation of cells and malignant progression. C-erbB-proteins are obviously not involved in carcinogenesis of CP.
叶状囊肉瘤(CP)是一种罕见的乳腺纤维上皮性肿瘤。目前尚无用于预测该肿瘤生物学行为及常常出人意料的临床结局的有价值的预后因素。
采用免疫组织化学方法,对17例良性和12例恶性CP进行检测,评估Mib-1的增殖活性,并分析p53、Bcl-2、c-erbB1、c-erbB2、细胞角蛋白和波形蛋白的表达情况。
恶性肿瘤的上皮和间叶部分的细胞增殖均显著高于良性肿瘤。在上皮部分,Bcl-2阳性细胞在良性病变中比在恶性病变中更常见。仅1例恶性病例p53免疫反应呈阳性,在上皮和间叶成分中均呈阳性反应。所有病例均未发现c-erbB蛋白表达。中间丝蛋白清楚地显示了肿瘤的两种成分。
我们得出结论,增殖活性增加和Bcl-2下调可能与细胞去分化和恶性进展有关。c-erbB蛋白显然不参与CP的致癌过程。